MedTrace Logo

Robot-assisted Esophagectomy Versus Conventional Thoracoscopic Esophagectomy

NCT03094351 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2020-02-05

No results posted yet for this study

Summary

This is the first randomized controlled study to compare the robot-assisted esophagectomy (RAE) to minimally invasive conventional thoracoscopic esophagectomy (CTE). The aim of this trial is to evaluate the safety, risks of the robot-assisted esophagectomy, and to compare the short-term operative outcomes and long-term oncological outcomes between the two surgical treatments.

Conditions

  • Esophageal Cancer
  • Esophageal Carcinoma

Interventions

PROCEDURE

esophagectomy

Robot assisted esophagectomy with extended two field lymphadenectomy.

PROCEDURE

esophagectomy

Conventional thoracoscopic esophagectomy with extended two field lymphadenectomy.

Sponsors & Collaborators

  • Ruijin Hospital

    collaborator OTHER

  • Changhai Hospital

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER

  • Shanghai Chest Hospital

    lead OTHER

Principal Investigators

  • Zhigang Li, Master · Shanghai Chest Hospital of Shanghai Jiao Tong University

  • Hecheng Li, Master · Ruijin Hospital

  • Hezhong Chen, Master · Changhai Hospital, the Second Military Medical University

  • Lijie Tan, Master · Fudan University

  • Bentong Yu, Master · The First of Affiliated Hospital of Nanchang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-29
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03094351 on ClinicalTrials.gov